Judge PK, Tuttle KR, Staplin N, Hauske SJ, et al. The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial. Nephrol Dial Transplant 2024 Nov 12:gfae263. doi: 10.1093.
PMID: 39533115